Entities / Company
Bio-Rad Laboratories.
American life science research firm
- Reports this week
- 0
- Active events
- 0
- Connections
- 63
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
-
Strategic acquisitions and product launches are driving growth for Bio-Rad Laboratories in the life science ddPCR and clinical diagnostics markets.Some support1 report1 development inside
-
Bio-Rad Laboratories is applying digital PCR technology through current partnerships, including Biodesix, Gencove, Insight Molecular, and Stilla Technologies.Some support1 report
One to three months ago
-
Bio-Rad Laboratories filed its required 13F reports with the SEC on September 7, 2026.Some support1 report
-
Bio-Rad Laboratories and BioLife Solutions, Inc. are life science companies that develop products marketed in the Middle East, Europe, and the US.Some support1 report
-
Vision 2030 is driving healthcare infrastructure investment in Saudi Arabia, fueled by the rise of chronic diseases and market growth.Some support1 report2 developments inside
-
Illumina and Bio-Rad Laboratories collaborate on advanced life science technologies.Some support1 report1 development inside
-
RBC lifted its price objective for Bio-Rad Laboratories, and Citigroup also raised its price objective for the company.Some support4 reports
-
Bio-Rad Laboratories reported sales growth in the Americas, while the NIH noted rising funding but lagging purchasing.Some support1 report
-
Bio-Rad Laboratories reported that its sales in China fell significantly in the high teens.Some support1 report
Gone quiet
No new reports in 90+ days-
GSK and Bio-Rad Laboratories are medical companies that are currently competing for investment.Some support1 report
-
A test highlighting value in personalized medicine is mentioned in a competitive market assessment involving Roche, Bio-Rad, and Charles River.Some support3 reports
-
Bio-Rad Laboratories is headquartered in Hercules, California.Some support3 reports
-
Phibro Animal Health's acquisition strengthens its ddPCR offering and expands into new markets.Some support1 report
-
Trump's pledge to unleash oil and gas benefits stocks, specifically involving Bio-Rad Laboratories.Some support1 report
-
Jim Barry joined Bio-Rad Laboratories on July 7, 2025, serving as EVP and President of the company's Life Science Group.Speculative1 report
-
Bio-Rad launched its QX Continuum digital PCR system, utilizing Nuvia wPrime 2A resin and Foresight Pro columns.Some support1 report
-
Major diagnostic companies, including Bio-Rad, Quest Diagnostics, and Myriad Genetics, are driving market growth.Some support1 report1 development inside
-
Saudi Arabia is a key region for the HPV testing market, with growth driven by diagnostic technology advancements from companies like Qiagen and Bio-Rad.Some support1 report
-
Mehta was appointed EVP Global Commercial Operations at Bio-Rad, while Crowley retired, and Mehta's past roles at Dow Chemical were noted.Some support1 report
-
Bio-Rad Laboratories acquired Stilla Technologies and received $250 million from Sartorius AG shares.Some support1 report
-
Bio-Rad Laboratories acquired Stilla Technologies and Norman Schwartz was appointed as Chairman and CEO.Some support2 reports
-
Market growth in the STD Diagnostic Market is being driven by technological advancements and increased STD prevalence.Some support1 report
-
Bio-Rad Laboratories' stock performance was compared against the Russell 2000 Index and HFRX Equity Hedge Index in September 2025.Some support1 report
-
The event mentions George Joseph as founder of Mercury, Alice Schwartz founding Bio-Rad, and groups Elon Musk and Mark Zuckerberg among young tech billionaires.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Bio-Rad Laboratories this week
News at the entities that move Bio-Rad Laboratories most-
Citigroup Mentioned togetherChina's regulator approved Citigroup's securities plan on October 23, 2026.Moves Bio-Rad Laboratories
-
National Institutes of Health TransactionalThe National Institutes of Health awarded funding for research and health programs to the University of Nebraska Medical Center.Moves Bio-Rad Laboratories
-
Royal Bank of Canada Mentioned togetherRBC and Citigroup boosted price objectives on Lockheed Martin shares, with MarketBeat aggregating the analyst ratings.Moves Bio-Rad Laboratories
-
Illumina OperationalCitigroup issued a rating report on Illumina, while MarketBeat aggregated the stock rating data.Moves Bio-Rad Laboratories
-
Charles River Laboratories OperationalFDA, LabCorp, and Charles River Laboratories formed a collaboration to evaluate the potential for medicine abuse.Moves Bio-Rad Laboratories
-
China Shared contextEU and Canada are seeking closer ties and allies in response to China's aggression, with Germany objecting to the associate membership label.Moves Bio-Rad Laboratories
Connections
The 11 strongest of 63, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
SEC Structural
Bio-Rad Laboratories is required to file regulatory reports, such as 13F filings, with the SEC to operate in the market.
-
Royal Bank of Canada Mentioned together
Royal Bank of Canada provides investment ratings and price objectives for Bio-Rad Laboratories stock.
-
Illumina Operational
The companies collaborate on advanced life science technologies.
-
Charles River Laboratories Operational
Both companies are described as competitors occupying vital positions within the biotech supply chain.
-
National Institutes of Health Transactional
NIH is noted as a potential purchaser of goods and services from Bio-Rad Laboratories.
-
China Shared context
Bio-Rad Laboratories operates within the Chinese market context, where sales performance is tracked.
-
Citigroup Mentioned together
Citigroup has published research reports raising its price target for Bio-Rad Laboratories.
-
MarketBeat Mentioned together
MarketBeat reports consensus recommendations related to Bio-Rad Laboratories.
History
Events by the month they beganSeptember 2026
3 events- Bio-Rad Laboratories is applying digital PCR technology through current partnerships, including Biodesix, Gencove, Insight Molecular, and Stilla Technologies.
- Bio-Rad Laboratories filed its required 13F reports with the SEC on September 7, 2026.
- Bio-Rad Laboratories and BioLife Solutions, Inc. are life science companies that develop products marketed in the Middle East, Europe, and the US.
August 2026
4 events- Strategic acquisitions and product launches are driving growth for Bio-Rad Laboratories in the life science ddPCR and clinical diagnostics markets.
- RBC lifted its price objective for Bio-Rad Laboratories, and Citigroup also raised its price objective for the company.
- Bio-Rad Laboratories reported sales growth in the Americas, while the NIH noted rising funding but lagging purchasing.
- Bio-Rad Laboratories reported that its sales in China fell significantly in the high teens.
July 2026
1 eventShow 1 earlier month
June 2026
16 events- Vision 2030 is driving healthcare infrastructure investment in Saudi Arabia, fueled by the rise of chronic diseases and market growth.
- GSK and Bio-Rad Laboratories are medical companies that are currently competing for investment.
- A test highlighting value in personalized medicine is mentioned in a competitive market assessment involving Roche, Bio-Rad, and Charles River.
- Bio-Rad Laboratories is headquartered in Hercules, California.
- Phibro Animal Health's acquisition strengthens its ddPCR offering and expands into new markets.
- Trump's pledge to unleash oil and gas benefits stocks, specifically involving Bio-Rad Laboratories.
- Jim Barry joined Bio-Rad Laboratories on July 7, 2025, serving as EVP and President of the company's Life Science Group.
- Bio-Rad launched its QX Continuum digital PCR system, utilizing Nuvia wPrime 2A resin and Foresight Pro columns.
- Major diagnostic companies, including Bio-Rad, Quest Diagnostics, and Myriad Genetics, are driving market growth.
- Saudi Arabia is a key region for the HPV testing market, with growth driven by diagnostic technology advancements from companies like Qiagen and Bio-Rad.
- Mehta was appointed EVP Global Commercial Operations at Bio-Rad, while Crowley retired, and Mehta's past roles at Dow Chemical were noted.
- Bio-Rad Laboratories acquired Stilla Technologies and received $250 million from Sartorius AG shares.
- Bio-Rad Laboratories acquired Stilla Technologies and Norman Schwartz was appointed as Chairman and CEO.
- Market growth in the STD Diagnostic Market is being driven by technological advancements and increased STD prevalence.
- Bio-Rad Laboratories' stock performance was compared against the Russell 2000 Index and HFRX Equity Hedge Index in September 2025.
- The event mentions George Joseph as founder of Mercury, Alice Schwartz founding Bio-Rad, and groups Elon Musk and Mark Zuckerberg among young tech billionaires.